Vivek Mundada

9PUBLICATIONS
5CO-AUTHORS
Molecular targetsGene and molecular therapyPeripheral nervous systemNeurology and neuromuscular diseasesMedical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 04, 2026
Determinants of hepatic enzyme elevations following onasemnogene abeparvovec: Results from a unified immunomodulation protocol.

|Apr 24, 2026
Delandistrogene moxeparvovec: gene therapy for Duchenne muscular dystrophy.

|Jan 06, 2026
Foot that spoke first: microvascular signs of a motor neuron disease.

Vivek Mundada

|Nov 10, 2025
Onasemnogene abeparvovec gene therapy for treatment of patients with spinal muscular atrophy: Updated real-world practical considerations.

Crystal M Proud, Elizabeth A Kichula, Susan E Matesanz

|Sep 23, 2024
Real-World Data in Children with Spinal Muscular Atrophy Type 1 on Long-Term Ventilation Receiving Gene Therapy: A Prospective Cohort Study.

Mohammad Ala' Alajjuri, Rania Abusamra, Vivek Mundada

|Aug 01, 2024
Onasemnogene abeparvovec gene therapy for spinal muscular atrophy: A cohort study from the United Arab Emirates.

Vivek Mundada, Omendra Narayan, Siddharth Arora

Pageof 2

Frequent Collaborators

1 joint publications

Mohammad Ala' Alajjuri

1 joint publications

Crystal M Proud

1 joint publications

Jennifer M Kwon

1 joint publications

Hugh J McMillan